SUBMIT BOOK PROPOSAL
Online Store
benthambooks logo

Site Breadcrumb

Frontiers in Clinical Drug Research -CNS and Neurological Disorders
View Sample

Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research -CNS and Neurological Disorders

Volume 3
eBook: US $79 Special Offer (PDF + Printed Copy): US $158
Printed Copy: US $119
Library License: US $316
ISSN: 2451-8883 (Print)
ISSN: 2214-7527 (Online)
ISBN: 978-1-60805-927-0 (Print)
ISBN: 978-1-60805-926-3 (Online)
Year of Publication: 2015
DOI: 10.2174/97816080592631140301
Rate This Book

Introduction

Frontiers in Clinical Drug Research - CNS and Neurological Disorders is an eBook series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders. The scope of the eBook series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of contemporary molecular targets involved in neurological and CNS disorders. Reviews presented in the series are mainly focused on clinical and therapeutic aspects of novel drugs intended for these targets. Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critical information for developing clinical trials and devising research plans in the field of neurology.

The third volume of this series features six chapters that cover a variety of topics including:

-the role of Potassium transport channels in neuroprotection against tetrahydroprotoberberines

-cannabinoids in cell therapy for CNS disorders

-AMPA Receptor Antagonists

-therapeutic intervention in polyglutamine ataxias

-nutritional therapies in neurology practice

Indexed in: Scopus, EMBASE, EBSCO.


eBook: US $79 Special Offer: US $158 Printed Copy: US $119 Library License: US $316

Contributors

Editor(s):
Atta-ur-Rahman FRS
Kings College, University of Cambridge
Honorary Life Fellow
Cambridge
UK



Contributor(s):
Antonio Laurenza
Clinical Development
Neuroscience & General Medicine Product Creation Unit, Eisai Inc., Woodcliff Lake
New Jersey
USA


Biswaroop Chakrabarty
Child Neurology Division, Department of Pediatrics
All India Institute of Medical Sciences
New Delhi
India


Claudio Cardinali
Department of Molecular Medicine
Sapienza University
Rome
Italy


Consuelo Amantini
School of Biosciences and Veterinary Medicine
University of Camerino
Camerino
Italy


Devin H. Taylor
Division of Neurology, Barrow Neurological Institute
St. Joseph’s Hospital and Medical Center, Phoenix
Luzhou Medical College
Arizona, 85013
USA


Giorgio Santoni
School of Pharmacy, Section of Experimental Medicine
University of Camerino
Camerino
Italy


Haichen Yang
Clinical Development
Neuroscience & General Medicine Product Creation Unit, Eisai Inc., Woodcliff Lake
New Jersey
USA


Ian James Martins
Centre of Excellence in Alzheimer’s Disease Research and Care
School of Medical Sciences, Edith Cowan University
270 Joondalup Drive
Joondalup, 6027
Australia
/
School of Psychiatry and Clinical Neurosciences
The University of Western Australia
Nedlands, 6009 and McCusker Alzheimer's Research Foundation
Hollywood Medical Centre, 85 Monash Avenue, Suite 22
Nedlands, 6009
Australia


Jie Wu
Division of Neurology, Barrow Neurological Institute
St. Joseph’s Hospital and Medical Center, Phoenix
Luzhou Medical College
Arizona, 85013
USA


Katsutoshi Ido
Global Biopharmacology, Neuroscience & General Medicine Product Creation Unit
Eisai Co. Ltd, Tsukuba
Ibaraki
Japan


Kechun Yang
Department of Neuroscience
University of Pennsylvania
Philadelphia
PA, 19104
USA


Manuela Lima
Centre of Research in Natural Resources (CIRN), Department of Biology
University of the Azores
Ponta Delgada
Portugal
/
Instituto de Investigação e Inovação em Saúde (Institute for Research and Innovation in Health)
University of Porto
Portugal
/
Portugal and Institute for Molecular and Cell Biology (IBMC)
University of Porto
Porto
Portugal


Maria Beatrice Morelli
Department of Molecular Medicine
Sapienza University
Rome
Italy


Massimo Nabissi
School of Pharmacy, Section of Experimental Medicine
University of Camerino
Camerino
Italy


Matteo Santoni
Medical Oncology, AOU Ospedali Riuniti
Polytechnic University of the Marche Region
Ancona
Italy


Nadiya Kazachkova
Centre of Research in Natural Resources (CIRN), Department of Biology
University of the Azores
Ponta Delgada
Portugal
/
Instituto de Investigação e Inovação em Saúde (Institute for Research and Innovation in Health),
University of Porto
Porto

/
Portugal and Institute for Molecular and Cell Biology (IBMC)
University of Porto
Porto
Portugal


Sheffali Gulati
Child Neurology Division, Department of Pediatrics
All India Institute of Medical Sciences
New Delhi
India


Sonia Liberati
School of Pharmacy, Section of Experimental Medicine
University of Camerino
Camerino
Italy


Takahisa Hanada
Global Biopharmacology, Neuroscience & General Medicine Product Creation Unit
Eisai Co. Ltd, Tsukuba
Ibaraki
Japan


Valerio Farfariello
Istituto Pasteur - Fondazione Cenci-Bolognetti
Roma
Italy


Valerio Napolioni
Department of Experimental Medicine
University of Perugia
Perugia
Italy



RELATED BOOKS

.Frontiers in Clinical Drug Research - CNS and Neurological Disorders.
.Frontiers in Clinical Drug Research - CNS and Neurological Disorders.
.Neurodegenerative Diseases: Multifactorial Degenerative Processes, Biomarkers and Therapeutic Approaches.
.Frontiers in Clinical Drug Research - CNS and Neurological Disorders.
.Traditional Medicine for Neuronal Health.
.Recent Advances in the Treatment of Neurodegenerative Disorders.
.Alzheimer
.Advances in Alzheimer Research.